Article
The impact of remdesivir on SARS-CoV-2 evolution in vivo.
JCI insight - 21 Jan 2025
Ling-Hu Ted, Simons Lacy M, Rios-Guzman Estefany, Carvalho Alexandre Machado, Agnes Maria Francesca R, Alisoltanidehkordi Arghavan, Ozer Egon A, Lorenzo-Redondo Ramon, Hultquist Judd F
Abstract excerpt
The impact of remdesivir on SARS-CoV-2 diversity and evolution in vivo has remained unclear. In this single-center, retrospective cohort study, we assessed SARS-CoV-2 diversification and diversity over time in a cohort of hospitalized patients who did or did not receive remdesivir. Whole-genome sequencing was performed on 98 paired specimens collected from 49 patients before and after remdesivir administration....
Topics
Join the communities discussing this publication.
